Robert Soros
CIK 1387524 · last filed 2017-09-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EXAR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
250 WEST 55TH STREET, FLOOR 38
NEW YORK, NY 10019
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXA CORP (EXA) Delisted | 10%+ Owner | 1,730,657 | — | — | $10.15M | 3 | 2017-09-21 |
| SIGMA DESIGNS INC (SIGM) Delisted | 10%+ Owner | 4,368,819 | — | — | $10.74M | 2 | 2017-06-09 |
| QUANTUM CORP /DE/ (QTM) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2015-01-30 |
| DRIV | 10%+ Owner | — | $30.44 | — | $0 | 6 | 2014-01-27 |
| WebMD Health Corp. (WBMD) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2013-10-02 |
| EXAR CORP (EXAR) Delisted | 10%+ Owner | 5,994,834 | — | — | -$13.67M | 4 | 2013-07-29 |
| MAP Pharmaceuticals, Inc. (MAPP) Delisted | 10%+ Owner | 2,826,169 | $28.11 | $79.44M | -$6.04M | 2 | 2010-03-16 |
| AUDC | 10%+ Owner | — | $11.20 | — | $0 | 1 | 2008-07-30 |
Recent Filings · Page 2 of 3
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-06-19 | EXAR CORP (EXAR) Delisted | Sell (S) | −107,634 | -$1.24M | EDGAR |
| 2012-12-05 | DRIV | Buy (P) | — | $0 | EDGAR |
| 2012-11-16 | DRIV | Buy (P) | — | $0 | EDGAR |
| 2012-11-06 | DRIV | Buy (P) | — | $0 | EDGAR |
| 2012-10-10 | EXAR CORP (EXAR) Delisted | Sell (S) | −900,000 | -$7.60M | EDGAR |
| 2012-10-09 | DRIV | Buy (P) | — | $0 | EDGAR |
| 2012-08-03 | DRIV | Buy (P) | — | $0 | EDGAR |
| 2011-03-17 | EXAR CORP (EXAR) Delisted | Buy (P) | +46,800 | $278.4K | EDGAR |
| 2010-03-16 | MAP Pharmaceuticals, Inc. (MAPP) Delisted | Sell (S) | −2,824 | -$45.5K | EDGAR |
| 2010-03-10 | MAP Pharmaceuticals, Inc. (MAPP) Delisted | Sell (S) | −406,284 | -$5.99M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.